BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Diagnosis
65 results:

  • 1. Integrated bioinformatics approach to unwind key genes and pathways involved in colorectal cancer.
    Mobeen SA; Saxena P; Jain AK; Deval R; Riazunnisa K; Pradhan D
    J Cancer Res Ther; 2023 Oct; 19(7):1766-1774. PubMed ID: 38376276
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
    Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
    JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
    Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
    Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Trends in pathology diagnoses during 10 years of a colorectal cancer screening programme.
    Carragher R; Ings GR; Baker G; Rosborough J; Johnston DB; Shah R; Cameron I; O'Neill C; Kelly PJ; McVeigh G; Irwin S; Khosraviani K; Dickey W; Owen TA; McKee CF; Coleman HG; Loughrey MB
    Histopathology; 2023 Nov; 83(5):756-770. PubMed ID: 37565291
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Role of miR-21 in the diagnosis of colorectal cancer: Meta-analysis and bioinformatics.
    Li J; Chen H; Sun G; Zhang X; Ye H; Wang P
    Pathol Res Pract; 2023 Aug; 248():154670. PubMed ID: 37418993
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Educational differences in healthcare use among survivors after breast, prostate, lung, and colon cancer - a SEQUEL cohort study.
    Levinsen AKG; Kjaer TK; Maltesen T; Jakobsen E; Gögenur I; Borre M; Christiansen P; Zachariae R; Laurberg S; Christensen P; Kroman N; Larsen SB; Degett TH; Hölmich LR; Brown PN; Johansen C; Kjær SK; Thygesen LC; Dalton SO
    BMC Health Serv Res; 2023 Jun; 23(1):674. PubMed ID: 37349718
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Harpain F; Dawoud C; Wimmer K; Schlager L; Kirchnawy S; Rizk D; Girgis K; Mittermair E; Oberndorfer F; Wöran K; Riss S; Stift A; Stift J
    Ann Surg Oncol; 2023 Jun; 30(6):3517-3527. PubMed ID: 36757514
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of novel characteristic biomarkers and immune infiltration profile for the anaplastic thyroid cancer via machine learning algorithms.
    Li C; Dong X; Yuan Q; Xu G; Di Z; Yang Y; Hou J; Zheng L; Chen W; Wu G
    J Endocrinol Invest; 2023 Aug; 46(8):1633-1650. PubMed ID: 36725810
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study.
    Amini M; Moradinazar M; Rajati F; Soofi M; Sepanlou SG; Poustchi H; Eghtesad S; Moosazadeh M; Harooni J; Aghazadeh-Attari J; Fallahi M; Fattahi MR; Ansari-Moghaddam A; Moradpour F; Nejatizadeh A; Shahmoradi M; Mansour-Ghanaei F; Ostadrahimi A; Ahmadi A; Khaledifar A; Saghi MH; Saki N; Mohebbi I; Homayounfar R; Farjam M; Nadimi AE; Kahnooji M; Pourfarzi F; Zamani B; Rezaianzadeh A; Johari MG; Mirzaei M; Dehghani A; Motlagh SFZ; Rahimi Z; Malekzadeh R; Najafi F
    BMC Public Health; 2022 Jul; 22(1):1401. PubMed ID: 35864469
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency.
    Alim I; Loke J; Yam S; Templeton AS; Newcomb P; Lindor NM; Pai RK; Jenkins MA; Buchanan DD; Gallinger S; Klugman S; Ostrer H
    Genet Med; 2022 Sep; 24(9):1821-1830. PubMed ID: 35616648
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Circulating Clusterin Levels and cancer Risk: A Systematic Review and Meta-Analysis.
    Beheshti Namdar A; Kabiri M; Mosanan Mozaffari H; Aminifar E; Mehrad-Majd H
    Cancer Control; 2022; 29():10732748211038437. PubMed ID: 35465749
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The prognostic value of extramural venous invasion in preoperative MRI of rectal cancer patients.
    Lehtonen TM; Koskenvuo LE; Seppälä TT; Lepistö AH
    Colorectal Dis; 2022 Jun; 24(6):737-746. PubMed ID: 35218137
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diagnostic usefulness of selected proteases and acute phase factors in patients with colorectal adenocarcinoma.
    Sebzda T; Gnus J; Dziadkowiec B; Latka M; Gburek J
    World J Gastroenterol; 2021 Oct; 27(39):6673-6688. PubMed ID: 34754160
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Being assigned a clinical nurse specialist is associated with better experiences of cancer care: English population-based study using the linked National cancer Patient Experience Survey and cancer Registration Dataset.
    Alessy SA; Lüchtenborg M; Rawlinson J; Baker M; Davies EA
    Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13490. PubMed ID: 34309952
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Underwater endoscopic mucosal resection versus endoscopic submucosal dissection for 20-30 mm colorectal polyps.
    Inoue T; Nakagawa K; Yamasaki Y; Shichijo S; Kanesaka T; Maekawa A; Higashino K; Uedo N; Ishihara R; Takeuchi Y
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2549-2557. PubMed ID: 33724540
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incidence and Risk of Various Types of Arterial Thromboembolism in Patients With cancer.
    Wang J; Kim YD; Kim CH
    Mayo Clin Proc; 2021 Mar; 96(3):592-600. PubMed ID: 33673912
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
    Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
    Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Predicted Chemotherapy Benefit for Breast cancer Patients With Germline Pathogenic Variants in cancer Susceptibility Genes.
    Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Katz SJ
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426465
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.